RTX A/S (RTX.CO)
| Previous close | 70.00 |
| Open | 71.20 |
| Bid | 0.00 x 0 |
| Ask | 70.40 x 0 |
| Day's range | 69.80 - 71.20 |
| 52-week range | 67.00 - 148.00 |
| Volume | |
| Avg. volume | 11,556 |
| Market cap | 574.651M |
| Beta (5Y monthly) | 1.18 |
| PE ratio (TTM) | 12.28 |
| EPS (TTM) | 5.70 |
| Earnings date | 24 Jan 2024 - 29 Jan 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 29 Jan 2021 |
| 1y target est | N/A |
GlobeNewswireRTX initiates a new share buy-back programme
Nørresundby, 30 November 2023Announcement no. 20/2023 The Board of Directors of RTX A/S has decided to initiate a new share buy-back programme of up to DKK 20 million to be executed during the period 1 December 2023 to 30 September 2024. The share buy-back programme is initiated pursuant to the authorization granted to the Board of Directors by the Annual General Meeting on 26 January 2023, which authorizes RTX to acquire treasury shares at a nominal value not exceeding 10% of the share capital.
- GlobeNewswire
Annual report 2022/23
Nørresundby, 30 November 2023Announcement no. 19/2023 Strong result for RTX in 2022/23Demand increased strongly in 2022/23 and led to record high revenue second year in a row. Contributing to this strong performance is the normalization of past years’ industry-wide challenges with component shortages and supply chain constraints. With continued focus on the development of our key accounts and offerings, RTX expects to continue the growth path in the coming years. However, we expect a temporary s
- GlobeNewswire
RTX signs strategic collaboration agreement for Healthcare solutions
Nørresundby, Denmark, 30 November 2023 Announcement no. 18/2023 RTX has signed a firm agreement with a large global Healthcare company on a strategic collaboration to bring to market a new generation of Wireless Continuous Patient Monitoring infrastructure solutions for the Hospital Healthcare sector. This partnership is expected to result in new product announcements from the second half of 2024. Healthcare is a segment, where RTX sees strong growth potential. Patients and providers in hospital
